Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Qui Tam Litigation: Peter Rost Suit Fails As Others Thrive

Executive Summary

While whistleblowers have been scoring big payouts in suits alleging off-label promotion and kickbacks, Peter Rost struck out in his seven-year suit against Pfizer.
Advertisement

Related Content

Rapamune Whistleblower Suit Gets Jolt From Government Intervention
Forest Admits To Knowingly Obstructing FDA Inspection In Guilty Pleas On Levothroid, Celexa Marketing
Health Care Fraud Investigations Bedevil Pharma Industry: If You're Not Under Investigation, It's Only Because You've Recently Settled
Whistleblower Must Show Pfizer Provided Kickbacks In Off-Label Promotion
Whistleblower Must Show Pfizer Provided Kickbacks In Off-Label Promotion

Topics

Advertisement
UsernamePublicRestriction

Register

PS052655

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel